EUVIMEDEUVIMED entdecken
Open Access

Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda

Anna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, Enock Kagimu iD, John Kasibante, Morris K Rutakingirwa, Edward Mpoza, Samuel Jjunju, Edwin Nuwagira, Rose Naluyima, Paul Kirumira, Cody Hou iD und 10 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Anna E Levin und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections, Cryptococcus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NINDS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is unknown whether persons with symptomatic cryptococcal meningitis detected during routine blood cryptococcal antigen (CrAg) screening have better survival than persons presenting with overt meningitis.

Methods

We prospectively enrolled Ugandans with HIV and cryptococcal meningitis from December 2018 to December 2021. Participants were treated with amphotericin-based combination therapy. We compared outcomes between persons who were CrAg screened then referred to hospital with those presenting directly to the hospital with symptomatic meningitis.

Results

Among 489 participants with cryptococcal meningitis, 40% (194/489) received blood CrAg screening and were referred to hospital (median time to referral 2 days; interquartile range [IQR], 1–6). CrAg-screened persons referred to hospital had lower 14-day mortality than non–CrAg-screened persons who presented directly to hospital with symptomatic meningitis (12% vs 21%; hazard ratio, .51; 95% confidence interval, .32–.83; P = .006). Fewer CrAg-screened participants had altered mental status versus non–CrAg-screened participants (29% vs 41%; P = .03). CrAg-screened persons had lower quantitative cerebrospinal fluid (CSF) culture burden (median [IQR], 4570 [11–100 000] vs 26 900 [182–324 000] CFU/mL; P = .01) and lower CSF opening pressures (median [IQR], 190 [120–270] vs 225 [140–340] mmH2O; P = .004) compared with non–CrAg-screened persons.

Conclusions

Survival from cryptococcal meningitis was higher in persons with prior CrAg screening than those without CrAg screening. Altered mental status was the most potent predictor for mortality in a multivariate model. We suggest that CrAg screening detects cryptococcal meningitis at an earlier stage, as evidenced by a favorable baseline risk profile and notably fewer persons with altered mental status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalHIV InfectionsCryptococcusHumansUgandaOutpatientsAntigens, FungalHospitals

Stichwörter der Autor:innen

AIDSadvanced HIV diseasecryptococcal antigenemiacryptococcal meningitis

Substanzen

Antigens, Fungal

Autor:innen und Institutionen

  • Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
  • Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

ORCID-Profile: Enock Kagimu, Cody Hou, Mahsa Abassi, Radha Rajasingham, Caleb P Skipper

Förderung

  • NCATS NIH HHS
  • NINDS NIH HHS
  • NIAID NIH HHS
  • NCRR NIH HHS
  • FIC NIH HHS
  • Wellcome Trust
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Levin, A. E., Bangdiwala, A. S., Nalintya, E., Kagimu, E., Kasibante, J., Rutakingirwa, M. K., Mpoza, E., Jjunju, S., Nuwagira, E., Naluyima, R., Kirumira, P., Hou, C., Ssebambulidde, K., Musubire, A. K., Williams, D. A., Abassi, M., Muzoora, C., Hullsiek, K. H., Rajasingham, R., …, & Skipper, C. P. (2023). Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac599

Vancouver

Levin AE, Bangdiwala AS, Nalintya E, Kagimu E, Kasibante J, Rutakingirwa MK, et al. Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac599

BibTeX
@article{Levin2023,
  author = {Levin, Anna E and Bangdiwala, Ananta S and Nalintya, Elizabeth and Kagimu, Enock and Kasibante, John and Rutakingirwa, Morris K and Mpoza, Edward and Jjunju, Samuel and Nuwagira, Edwin and Naluyima, Rose and Kirumira, Paul and Hou, Cody and Ssebambulidde, Kenneth and Musubire, Abdu K and Williams, Darlisha A and Abassi, Mahsa and Muzoora, Conrad and Hullsiek, Katherine H and Rajasingham, Radha and Meya, David B and Boulware, David R and Skipper, Caleb P},
  title = {Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac599}
}
Kostenlos starten →